Developer docs
API playgroundTry for free, no card

Search company profiles

The Foundry

Full company profile

uuid0007k9y

Namestring
The Foundry
Legal namestring
The Foundry, LLC
Websiteurl
thefoundry.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

The Foundry, LLC is a privately held medical device and biotechnology incubator founded in 1998 in Menlo Park, California, that identifies unmet clinical needs and forms, funds, and operates companies to commercialize innovative medical technologies. The firm operates a portfolio-based platform rather than a single product line, having developed more than 20 companies since inception across cardiovascular (Ardian, Twelve, Mavericks Endo, Half Moon Medical), neurovascular/stroke (Concentric Medical), structural heart (Evalve/MitraClip), pulmonary/respiratory (Emphasys/Zephyr, Nuvaira, Apreo Health), pain management (Allay Therapeutics), drug delivery (Foundry Therapeutics), ophthalmology (ForSight Labs, Transcend Medical, ForSight Vision2), and aesthetics (Cabochon, Miramar Labs) verticals. Its underlying technology stack consists of an integrated R&D infrastructure located at its Menlo Park headquarters — including wet lab, chemistry development facility, machine shop, and clean room — combined with a team of operating partners and a 500+ patent portfolio that has produced multiple category-defining devices now standard-of-care.

The Foundry generates revenue primarily through equity ownership in its portfolio companies, with exits typically occurring via acquisition by strategic medical device companies (Medtronic acquired Ardian for $850M in 2011 and Twelve for $458M in 2015; Abbott acquired Evalve for $410M in 2009; Stryker acquired Concentric Medical for $135M in 2011; Pulmonx acquired Emphasys in 2009). Portfolio companies have collectively raised approximately $1B from more than 50 venture capital firms and corporations, generating over $3B in aggregate shareholder value. Customers of the underlying therapies are hospitals, physicians, and patients; the firm itself sells nothing directly to end users. Active development-stage companies include Allay Therapeutics, Apreo Health, Mavericks Endo, FIRE1 (Dublin), Foundry Therapeutics, Nuvaira, and Half Moon Medical, with the Half Moon Medical program operating under a strategic development partnership with Medtronic. The company employs 1-10 people at the parent-entity level and is led by Managing Partner Hanson S. Gifford III, a named inventor on 370+ US patents.

Short descriptiontext

The Foundry is a Menlo Park-based medical device incubator founded in 1998 that forms, funds, and operates companies developing category-defining medical technologies, having created 20+ portfolio companies and $3B+ in shareholder value through strategic exits.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device incubator, medical technology development, healthcare venture building, clinical innovation platform, medical device company creation
Industry3 codes
1Process Development & Tech Transfer Services (CDMO)
CodeHLAGABALPrimaryYes
2Process Development & Tech Transfer (Upstream/Downstream/MSAT)
CodeHLAGAGAEPrimaryNo
3CMC, Process Development & Tech Transfer Staffing FSP
CodeHLAGAOAKPrimaryNo
NAICS code1 code
  • Machinery Manufacturing333
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Medical Device Incubation Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Equity stakes in portfolio companies
TypeLicensing Royalties
Description

The Foundry generates returns through equity ownership in the companies it develops and incubates. Companies are formed around innovative medical technologies and typically raised funding from VCs and corporations before being acquired by major medical device companies.

thefoundry.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Foundry is a medical device company incubator that identifies unmet clinical needs and builds independent companies around innovative medical technologies. The firm provides integrated R&D facilities (wet lab, chemistry development, machine shop, clean room), an experienced leadership team, funding capabilities, and an extensive network of VCs and strategic partners to take technologies from concept through development, clinical milestones, and ultimately acquisition or commercialization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • $3B+ in shareholder value created
+3 more records
Product overview1 text field

The Foundry is a medical technology incubator that identifies unmet clinical needs and builds companies around innovative technologies that address them. Rather than a single unified product, The Foundry operates as a portfolio-based platform that has developed over 20 medical device and biotechnology companies since 1998. The core products include landmark medical devices such as the Symplicity Catheter System (by Ardian), Zephyr Valve (by Emphasys Medical), Merci Retriever (by Concentric Medical), and MitraClip (by Evalve) - all of which have been successfully acquired by major medical device companies. The portfolio spans multiple therapeutic areas including cardiovascular, stroke/neurovascular, respiratory/pulmonary, ophthalmology, pain management, and medical aesthetics. The portfolio companies include legacy companies (like Ardian, Concentric Medical, Evalve, Emphasys Medical that were acquired) and active companies (like Allay Therapeutics, Apreo Health, FIRE1, Nuvaira, Half Moon Medical, Mavericks Endo). The Foundry provides facilities, expertise, and resources to develop these technologies from concept to market.

Product and service8 records
1The Foundry Medical Device Incubation Service
CategoryMedical device incubation
2Allay Therapeutics
CategoryPortfolio company - Pain management therapeutics
3Apreo Health
CategoryPortfolio company - Pulmonary medical devices
4FIRE1
CategoryPortfolio company - Heart failure monitoring
5Foundry Therapeutics
CategoryPortfolio company - Drug delivery platform
6Half Moon Medical
CategoryPortfolio company - Transcatheter mitral valve repair
7Mavericks Endo
CategoryPortfolio company - Vascular repair devices
8Nuvaira
CategoryPortfolio company - Respiratory disease treatment
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-10-14
Description

Medtronic announced a partnership with The Foundry in October 2020 to develop innovative mitral valve repair technology. Half Moon Medical's technology was being evaluated in an early feasibility study. This builds on The Foundry's history with Medtronic, which has acquired multiple Foundry portfolio companies including Ardian and Twelve.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2014-01-01
Description

FIRE1 was formed in 2014 as a partnership with Covidien Ventures to develop a heart failure monitoring solution which measures circulating blood volume to improve outcomes for heart failure patients. FIRE1 is based in Dublin, Ireland.

3Dr. Eugene de Juan, Jr. and K. Angela Macfarlane
Strategic tierCoreTypeStrategic or Co-development Partner
Description

ForSight Labs, an ophthalmic company incubator, was formed in 2005 in partnership with Dr. Eugene de Juan, Jr. and K. Angela Macfarlane. Six companies were formed to develop treatments for glaucoma, retinal diseases, conjunctivitis and dry eye.

thefoundry.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Half Moon Medical was formed in 2017 in partnership with Medtronic to develop a transcatheter device for mitral valve repair to restore function in patients with severe symptomatic mitral regurgitation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medical device and combination-product incubator founded by Mir Imran in the San Francisco Bay Area. Operates a similar concept-to-company model with integrated R&D facilities and equity stakes in portfolio companies, making it the closest comparable to The Foundry.

TypeDirect peer
Description

Medical device incubator co-founded by many of the same individuals involved in The Foundry's ecosystem. Builds and invests in early-stage medical device companies with a comparable lab-to-company approach.

TypeDirect peer
Description

Medical device incubator founded by Josh Makower that created multiple companies later acquired by Covidien/Medtronic (e.g., NeoTract). Direct structural peer in the medical-device company-building model.

TypeDirect peer
Description

Ophthalmic company incubator formed in 2005 in partnership with The Foundry itself. Operates the same incubator model in a narrower ophthalmology vertical, making it a direct intra-portfolio comparable.

5Nualas
TypeEmerging player
Description

Early-stage medical device incubator with a similar company-formation model focused on unmet clinical needs. Smaller and less proven than The Foundry, but operates on a comparable playbook.

TypeBroad incumbent
Description

Healthcare-focused venture capital firm with active medical device practice. While primarily a fund rather than an incubator, it co-invests in similar early-stage medical device companies and provides comparable capital deployment.

TypeOthers
Description

Healthcare and medical device venture capital firm where The Foundry's Managing Partner Hanson Gifford also serves as a Partner. Direct ecosystem overlap makes it a relevant adjacent peer.

TypeOthers
Description

Major venture capital firm with disclosed investment activity in The Foundry-affiliated portfolio companies (2013 and 2018 funding rounds). Represents a key financial partner in The Foundry's portfolio.

TypeOthers
Description

Healthcare-focused venture firm that co-invested in The Foundry-affiliated portfolio company funding rounds (2010). Relevant as a recurring financial partner in the Foundry ecosystem.

TypeOthers
Description

Healthcare venture capital firm that participated in The Foundry-affiliated portfolio company financing rounds (2010). Functions as an enabling financial peer in the same company-building ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Foundry

Medical Device Incubation Servicesthefoundry.com

The Foundry is a Menlo Park-based medical device incubator founded in 1998 that forms, funds, and operates companies developing category-defining medical technologies, having created 20+ portfolio companies and $3B+ in shareholder value through strategic exits.

What The Foundry does

The Foundry, LLC is a privately held medical device and biotechnology incubator founded in 1998 in Menlo Park, California, that identifies unmet clinical needs and forms, funds, and operates companies to commercialize innovative medical technologies. The firm operates a portfolio-based platform rather than a single product line, having developed more than 20 companies since inception across cardiovascular (Ardian, Twelve, Mavericks Endo, Half Moon Medical), neurovascular/stroke (Concentric Medical), structural heart (Evalve/MitraClip), pulmonary/respiratory (Emphasys/Zephyr, Nuvaira, Apreo Health), pain management (Allay Therapeutics), drug delivery (Foundry Therapeutics), ophthalmology (ForSight Labs, Transcend Medical, ForSight Vision2), and aesthetics (Cabochon, Miramar Labs) verticals. Its underlying technology stack consists of an integrated R&D infrastructure located at its Menlo Park headquarters — including wet lab, chemistry development facility, machine shop, and clean room — combined with a team of operating partners and a 500+ patent portfolio that has produced multiple category-defining devices now standard-of-care.

The Foundry generates revenue primarily through equity ownership in its portfolio companies, with exits typically occurring via acquisition by strategic medical device companies (Medtronic acquired Ardian for $850M in 2011 and Twelve for $458M in 2015; Abbott acquired Evalve for $410M in 2009; Stryker acquired Concentric Medical for $135M in 2011; Pulmonx acquired Emphasys in 2009). Portfolio companies have collectively raised approximately $1B from more than 50 venture capital firms and corporations, generating over $3B in aggregate shareholder value. Customers of the underlying therapies are hospitals, physicians, and patients; the firm itself sells nothing directly to end users. Active development-stage companies include Allay Therapeutics, Apreo Health, Mavericks Endo, FIRE1 (Dublin), Foundry Therapeutics, Nuvaira, and Half Moon Medical, with the Half Moon Medical program operating under a strategic development partnership with Medtronic. The company employs 1-10 people at the parent-entity level and is led by Managing Partner Hanson S. Gifford III, a named inventor on 370+ US patents.

The Foundry firmographics

Firmographics
Name
The Foundry
Legal name
The Foundry, LLC
Website
https://thefoundry.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
1–10 employees
Short description
The Foundry is a Menlo Park-based medical device incubator founded in 1998 that forms, funds, and operates companies developing category-defining medical technologies, having created 20+ portfolio companies and $3B+ in shareholder value through strategic exits.
Ownership category
akta.pro rank

The Foundry industry classification

Industry
Product category
Medical Device Incubation Services
NAICS
Machinery Manufacturing (333)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Process Development & Tech Transfer Services (CDMO) (HLAGABAL)
akta.pro secondary industries
Process Development & Tech Transfer (Upstream/Downstream/MSAT) (HLAGAGAE), CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)

Keywords

  • Medical device incubator
  • Medical technology development
  • Healthcare venture building
  • Clinical innovation platform
  • Medical device company creation

Where The Foundry is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Foundry business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Equity stakes in portfolio companies: The Foundry generates returns through equity ownership in the companies it develops and incubates. Companies are formed around innovative medical technologies and typically raised funding from VCs and corporations before being acquired by major medical device companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

The Foundry product offering

Product offering

Core offering

The Foundry is a medical device company incubator that identifies unmet clinical needs and builds independent companies around innovative medical technologies. The firm provides integrated R&D facilities (wet lab, chemistry development, machine shop, clean room), an experienced leadership team, funding capabilities, and an extensive network of VCs and strategic partners to take technologies from concept through development, clinical milestones, and ultimately acquisition or commercialization.

Product overview

The Foundry is a medical technology incubator that identifies unmet clinical needs and builds companies around innovative technologies that address them. Rather than a single unified product, The Foundry operates as a portfolio-based platform that has developed over 20 medical device and biotechnology companies since 1998. The core products include landmark medical devices such as the Symplicity Catheter System (by Ardian), Zephyr Valve (by Emphasys Medical), Merci Retriever (by Concentric Medical), and MitraClip (by Evalve) - all of which have been successfully acquired by major medical device companies. The portfolio spans multiple therapeutic areas including cardiovascular, stroke/neurovascular, respiratory/pulmonary, ophthalmology, pain management, and medical aesthetics. The portfolio companies include legacy companies (like Ardian, Concentric Medical, Evalve, Emphasys Medical that were acquired) and active companies (like Allay Therapeutics, Apreo Health, FIRE1, Nuvaira, Half Moon Medical, Mavericks Endo). The Foundry provides facilities, expertise, and resources to develop these technologies from concept to market.

Differentiator

Problem solved

Functional benefit

Products and services

  • The Foundry Medical Device Incubation Service
  • Allay Therapeutics
  • Apreo Health
  • FIRE1
  • Foundry Therapeutics
  • Half Moon Medical
  • Mavericks Endo
  • Nuvaira

Quantifiable outcome

  • $3B+ in shareholder value created
  • +3 more outcomes

Companies that use The Foundry

Customer profile

Named customers5 records

Segments1 record

Ideal customer profiles2 records

The Foundry technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

The Foundry partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • MedtroniccoreStrategic or Co-development Partner · 14 October 2020Medtronic announced a partnership with The Foundry in October 2020 to develop innovative mitral valve repair technology. Half Moon Medical's technology was being evaluated in an early feasibility study. This builds on The Foundry's history with Medtronic, which has acquired multiple Foundry portfolio companies including Ardian and Twelve.
  • Covidien VenturescoreStrategic or Co-development Partner · 1 January 2014FIRE1 was formed in 2014 as a partnership with Covidien Ventures to develop a heart failure monitoring solution which measures circulating blood volume to improve outcomes for heart failure patients. FIRE1 is based in Dublin, Ireland.
  • Dr. Eugene de Juan, Jr. and K. Angela MacfarlanecoreStrategic or Co-development PartnerForSight Labs, an ophthalmic company incubator, was formed in 2005 in partnership with Dr. Eugene de Juan, Jr. and K. Angela Macfarlane. Six companies were formed to develop treatments for glaucoma, retinal diseases, conjunctivitis and dry eye.
  • Medtronic (Half Moon Medical)coreStrategic or Co-development PartnerHalf Moon Medical was formed in 2017 in partnership with Medtronic to develop a transcatheter device for mitral valve repair to restore function in patients with severe symptomatic mitral regurgitation.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

The Foundry competitors and assessment

Company assessment

Direct peers

  • InCube Labs: Medical device and combination-product incubator founded by Mir Imran in the San Francisco Bay Area. Operates a similar concept-to-company model with integrated R&D facilities and equity stakes in portfolio companies, making it the closest comparable to The Foundry.
  • Synecor: Medical device incubator co-founded by many of the same individuals involved in The Foundry's ecosystem. Builds and invests in early-stage medical device companies with a comparable lab-to-company approach.
  • ExploraMed: Medical device incubator founded by Josh Makower that created multiple companies later acquired by Covidien/Medtronic (e.g., NeoTract). Direct structural peer in the medical-device company-building model.
  • ForSight Labs: Ophthalmic company incubator formed in 2005 in partnership with The Foundry itself. Operates the same incubator model in a narrower ophthalmology vertical, making it a direct intra-portfolio comparable.

Emerging players

  • Nualas: Early-stage medical device incubator with a similar company-formation model focused on unmet clinical needs. Smaller and less proven than The Foundry, but operates on a comparable playbook.

Broad incumbents

  • Longitude Capital: Healthcare-focused venture capital firm with active medical device practice. While primarily a fund rather than an incubator, it co-invests in similar early-stage medical device companies and provides comparable capital deployment.

Others

  • Lightstone Ventures: Healthcare and medical device venture capital firm where The Foundry's Managing Partner Hanson Gifford also serves as a Partner. Direct ecosystem overlap makes it a relevant adjacent peer.
  • New Enterprise Associates (NEA): Major venture capital firm with disclosed investment activity in The Foundry-affiliated portfolio companies (2013 and 2018 funding rounds). Represents a key financial partner in The Foundry's portfolio.
  • Domain Associates: Healthcare-focused venture firm that co-invested in The Foundry-affiliated portfolio company funding rounds (2010). Relevant as a recurring financial partner in the Foundry ecosystem.
  • Versant Ventures: Healthcare venture capital firm that participated in The Foundry-affiliated portfolio company financing rounds (2010). Functions as an enabling financial peer in the same company-building ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

The Foundry social profiles

Digital presence

The Foundry financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Foundry leadership team

Management profile

Number of profiles

Profiles4 records

The Foundry subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

The Foundry funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Foundry M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Foundry

What does The Foundry do?

The Foundry is a medical device company incubator that identifies unmet clinical needs and builds independent companies around innovative medical technologies. The firm provides integrated R&D facilities (wet lab, chemistry development, machine shop, clean room), an experienced leadership team, funding capabilities, and an extensive network of VCs and strategic partners to take technologies from concept through development, clinical milestones, and ultimately acquisition or commercialization.

Is The Foundry a public or private company?

The Foundry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The Foundry founded?

The Foundry was founded in 1998. It employs 1 to 10 people.

Where is The Foundry based?

The Foundry is headquartered in Menlo Park, United States, in the North America region.

How does The Foundry make money?

One revenue line is on record: equity stakes in portfolio companies.

Who are The Foundry's main competitors?

Direct peers on record are InCube Labs, Synecor, ExploraMed and ForSight Labs. Nualas is listed as an emerging player. Longitude Capital is listed as a broad incumbent. Others are Lightstone Ventures, New Enterprise Associates (NEA), Domain Associates and Versant Ventures.

Does The Foundry have an API?

No public API is recorded for The Foundry.

What industry is The Foundry in?

The Foundry's product category is Medical Device Incubation Services. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT). Its NAICS code is 333 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup SceneThe Foundry is Creating Startups From Problems, Not PitchesThe Foundry, a Cairo-based venture builder founded in January 2026, creates AI-native B2B products from operational problems. It raised EGP 34 million in three weeks, giving a two-year runway, and has eight products in development with four launching soon. The company plans to focus on delivering its built products rather than further fundraising.ProlificnorthMountain Equipment relaunches iconic climbing range with film-led campaign from The FoundryMountain Equipment relaunched its Stonewear climbing range with a new campaign from The Foundry, featuring a three-minute film shot in North Wales. The campaign focuses on the 'wait' and climbing culture, and the launch is rolling out across digital and retail channels.NDTV ProfitThe Foundery: What Founders Should Know Before Applying To Kamath And Biyani's VentureAn analysis of The Foundery, a co-founder identification programme by Nikhil Kamath and Kishore Biyani, has revealed that its Terms and Conditions grant organizers wide discretion over selection, elimination, and participant replacement while limiting their liability. The programme promises 30 selectees up to Rs 4 crore in investment and up to 25% equity in affiliate-promoted ventures, but legal experts note that equity is not guaranteed and founders must waive all intellectual property rights—including copyright, publicity rights, and moral rights—over submitted content, which can affect future fundraising and positioning. Lawyers recommend that applicants carefully review clauses around discretion, equity, IP ownership, and communication restrictions before applying, as these terms can compound over time as a founder's profile grows.VulcanpostMost would retire, but this senior couple learnt to make gelato from scratch & sells 500kg/monthRetired couple Tan Kian Tat and Zheng Yazhu, aged 73 and 77, run Freshio Gelato in Singapore, making gelato from scratch. They sell about 500kg monthly and opened a new outlet in late March. They plan to keep working with intergenerational collaboration.LinkedInSemiconductor Private Equity Investment Falls 45% YoY to $13.35BThe article discusses the importance of social, human, and financial capital in building resilient ecosystems, citing a speech by Jacqueline Novogratz at The Foundry, which is a space aimed at supporting impact sector organizations. The focus is on collective efforts to change conditions and improve outcomes.PR NewswireMedtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair TechnologyMedtronic plc announced a partnership with The Foundry dating back to mid-2017 to develop an innovative transcatheter mitral valve repair technology (TMVr), creating a new company called Half Moon Medical. Half Moon Medical recently received U.S. FDA approval for an early feasibility study in patients with severe, symptomatic mitral regurgitation, with first implants expected in the coming weeks. The partnership includes structured investment tranches and an exclusive right for Medtronic to acquire Half Moon Medical contingent upon achievement of technical and clinical milestones, potentially complementing Medtronic's existing Intrepid Transcatheter Valve Replacement System.Welcome to MedtronicMedtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair TechnologyMedtronic has announced that Half Moon Medical is ready to begin an early feasibility study for its innovative transcatheter mitral valve repair technology, following FDA approval. This development stems from a strategic partnership between Medtronic and The Foundry, which includes an exclusive option for Medtronic to acquire Half Moon Medical upon meeting specific clinical milestones. The device aims to treat severe mitral regurgitation by restoring valve function through a minimally invasive approach.GlobeNewswireFoundry SING1 Launches, Targets Asian Clinical NeedsFoundry and Lightstone Ventures launched Foundry SING1 to address unmet clinical needs in Asia, naming Karun D. Naga CEO. The company will leverage Singapore's medtech ecosystem, with Lightstone Singapore as initial investor. It aims to develop solutions for Asian markets with global implementation.RedShark NewsThe Foundry Reveals NUKE 9The Foundry unveiled NUKE 9 in October 2014, described as the biggest overhaul of its visual effects compositing software, introducing NUKE Studio which adds timeline-based editing to the existing node-based compositing tools. The release includes new pricing options with monthly subscriptions and a free non-commercial version, alongside hardware certification for HP workstations with NVIDIA graphics and Blackmagic I/O for real-time 4K playback. NUKE 9 and NUKE Studio became available by the end of November 2014, marking The Foundry's first release to support the new Mac Pro.VC News DailyThe Foundry Forges FIRE1 With Early FundingThe Foundry, a medical device incubator, has launched a new therapeutic device company called FIRE1 in Dublin, Ireland, with joint early-stage investments from Lightstone Ventures and New Enterprise Associates (NEA). The Series A funding will support FIRE1's development and commercialization of solutions for unmet medical needs. FIRE1 marks The Foundry's first company created in Ireland, a region that has become a leading cluster for medical devices globally.